Form 4 for ABOS Acumen Pharmaceuticals, Inc.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001209191-21-046029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-08 | 2021-07-06 | ABOS | OConnell Daniel Joseph | Pres, CEO, Dir | X - OptEx | $4.47 | +35 | 1,577 | +2% | +$156.45 |
| D | 2021-07-08 | 2021-07-06 | ABOS | OConnell Daniel Joseph | Pres, CEO, Dir | C - Cnv Deriv | — | +123 | 1,542 | +9% | — |
| D | 2021-07-08 | 2021-07-06 | ABOS | OConnell Daniel Joseph | Pres, CEO, Dir | F - Tax | $16.00 | -10 | 1,567 | -0.6% | -$160 |
| D | 2021-07-08 | 2021-07-06 | ABOS | OConnell Daniel Joseph | Pres, CEO, Dir | M - OptEx | $0.00 | -35 | 0 | -100% | $0 |
| D | 2021-07-08 | 2021-07-06 | ABOS | OConnell Daniel Joseph | Pres, CEO, Dir | C - Cnv Deriv | — | -123 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | X | A | 35 | $4.47 | 1,577 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-06 | C | A | 123 | — | 1,542 | D | — | — | (F1) On July 6, 2021, each share of Series A Convertible Preferred Stock (the "Preferred Stock") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. |
| 3 | Common | Common Stock | 2021-07-06 | F | D | 10 | $16.00 | 1,567 | D | — | — | |
| 4 | Derivative | Warrant (Right to Buy) | 2021-07-06 | M | D | 35 | $0.00 | 0 | D | $4.47 · 2020-12-31 to 2025-06-30 | 35 Common Stock | |
| 5 | Derivative | Series A Preferred Stock | 2021-07-06 | C | D | 123 | — | 0 | D | — · — to — | 123 Common Stock | (F1) On July 6, 2021, each share of Series A Convertible Preferred Stock (the "Preferred Stock") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. |